Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/32767

TitlePhospho-mTOR in non-tumour and tumour bladder urothelium : pattern of expression and impact on urothelial bladder cancer patients
Author(s)Afonso, Julieta Alexandra Pereira
Longatto Filho, Adhemar
Silva, Vitor Moreira
Amaro, T.
Santos, L. L.
KeywordsP-mTOR
Urothelial bladder cancer
Pattern of expression
Umbrella cells
Issue date2014
PublisherSpandidos Publications
JournalOncology Letters
Abstract(s)Urothelial bladder carcinoma (UBC) is heterogeneous in its pathology and clinical behaviour. Evaluation of prognostic and predictive biomarkers is necessary, in order to produce personalised treatment options. The present study used immunohistochemistry to evaluate UBC sections containing tumour and non-tumour areas from 76 patients, for the detection of p-mTOR, CD31 and D2-40 (blood and lymphatic vessels identification, respectively). Of the non-tumour and tumour sections, 36 and 20% were scored positive for p-mTOR expression, respectively. Immunoexpression was observed in umbrella cells from non-tumour urothelium, in all cell layers from non-muscle-invasive (NMI) tumours (including expression in superficial cells), and in spots of cells from muscle-invasive (MI) tumours. Positive expression decreased from non-tumour to tumour urothelium, and from pT1/pTis to pT3/pT4 tumours; however, the few pT3/pT4 positive cases had worse survival rates, with 5-year disease-free survival being significantly lower. Angiogenesis occurrence was impaired in pT3/pT4 tumours that did not express p-mTOR. In conclusion, p-mTOR expression in non-tumour umbrella cells is likely a reflection of their metabolic plasticity, and extension to the inner layers of the urothelium in NMI tumours is consistent with an enhanced malignant potential. The expression in cell spots in a few MI tumours and absence of expression in the remaining tumours is intriguing and requires further research. Additional studies regarding the up- and downstream effectors of the mTOR pathway should be conducted
TypeArticle
URIhttp://hdl.handle.net/1822/32767
DOI10.3892/ol.2014.2392
ISSN1792-1082
Publisher versionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156165/
Peer-Reviewedyes
AccessOpen access
Appears in Collections:ICVS - Artigos em Revistas Internacionais com Referee

Files in This Item:
File Description SizeFormat 
afonso j_oncol lett 2014.pdf636,85 kBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID